AI Verdict
NBHC has stronger fundamentals based on our AI analysis.
NBY vs NBHC Fundamental Comparison
| Metric | NBY | NBHC |
|---|---|---|
| Revenue | $521,000.0 | $47.1M |
| Net Income | $-22.1M | $109.6M |
| Net Margin | -4,249.7% | 232.6% |
| ROE | N/A | 7.9% |
| ROA | -245.1% | 1.1% |
| Current Ratio | 7.60x | N/A |
| Debt/Equity | N/A | 0.04x |
| EPS | $0.76 | $2.85 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
NBY vs NBHC: Frequently Asked Questions
Is NBY or NBHC a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), NBHC has stronger fundamentals. NBY is rated STRONG SELL (95% confidence) while NBHC is rated HOLD (72% confidence). This is not investment advice.
How does NBY compare to NBHC fundamentally?
NovaBay Pharmaceuticals, Inc. has ROE of N/A vs National Bank Holdings Corp's 7.9%. Net margins are -4,249.7% vs 232.6% respectively.
Which stock pays higher dividends, NBY or NBHC?
NBY has a dividend yield of N/A or no dividend while NBHC has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in NBY or NBHC for long term?
For long-term investing, consider that NBY has STRONG SELL rating with 95% confidence, while NBHC has HOLD rating with 72% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about NBY vs NBHC?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For NBY vs NBHC, the AI consensus favors NBHC based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.